Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Cohort for Monitoring Patients With Venous Thromboembolic Disease
Clinical trial is currently recruiting to monitor patients with venous thromboembolism. The study is sponsored by University Hospital, Rouen…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Diffrence in Thromboprofilaksis in Elderly Ostoepenic Hip Fractures According to Mobility Status by Genetic Analysis [NA]
A clinical trial registry entry about differences in thromboprophylaxis for elderly osteopenic hip fracture patients based on mobility statu…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism [NA]
This clinical trial entry outlines a study sponsored by Navy General Hospital, Beijing, evaluating smart technology-enabled, patient-centere…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: The Impact of MTM Model on the Efficacy and Safety of Anticoagulant Therapy in Postoperative Colorectal Cancer Patients [NA]
A clinical trial update noting a study on the MTM Model's impact on the efficacy and safety of anticoagulant therapy in postoperative colore…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Smart Technology Facilitated Patient-centered Venous Thromboembolism Management [NA]
A clinical trial by Navy General Hospital, Beijing is evaluating smart-technology-enabled, patient-centered management of venous thromboembo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis [Phase 4]
This update indicates a Phase 4 trial investigating secondary prevention of venous thromboembolism in cancer patients with catheter-related …
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism [Phase 4]
A Phase 4 trial comparing clinical surveillance versus anticoagulation for low-risk patients with isolated subsegmental pulmonary embolism i…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial [Phase 4]
Phase 4 clinical trial ARTS evaluating strategies to reduce risks of venous thromboembolism and bleeding during surgery is currently recruit…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure
A clinical trial update for a study examining risk factors for venous thromboembolism in women during hormonal exposure; recruitment is ongo…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk [Phase 4]
Phase 4 clinical trial evaluating prevention of postpartum venous thromboembolism in women at intermediate risk is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"
Registry entry for a study on thromboembolism and cancer by the Sociedad Española de Oncología Médica is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism [Phase 2]
Phase 2 clinical trial evaluating antithrombin to improve thromboprophylaxis and reduce trauma-related venous thromboembolism; currently enr…
-
FDA approval · 2025-05-14FDA Approved: RIVAROXABAN — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' original ANDA for rivaroxaban, making a generic rivaroxaban available in the U.S. for approved indic…
-
FDA approval · 2025-05-14FDA Approved: RIVAROXABAN — Original Application (Dr.Reddy's Laboratories, Inc.)
FDA approved Dr. Reddy's Laboratories' generic rivaroxaban for marketing (ANDA 208534), expanding access to the direct oral anticoagulant. T…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure [NA]
PAUSE-2 is a clinical trial evaluating perioperative management of direct oral anticoagulants (dabigatran, rivaroxaban, apixaban, and edoxab…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty [Phase 2]
Phase II clinical study of H001 Capsule to prevent venous thromboembolism after total knee arthroplasty is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Ongoing Registry of Treatment of Venous Thromboembolism
This document reports an ongoing registry study on the treatment of venous thromboembolism. It is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis [Phase 4]
A Phase 4 clinical trial comparing pulsed electromagnetic field therapy versus pneumatic compression for venous thromboembolism prophylaxis …
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
A clinical trial aims to develop and apply a thrombosis risk prediction model in lung cancer patients treated with immune checkpoint inhibit…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery [NA]
Clinical trial comparing rivaroxaban to enoxaparin for preventing venous thromboembolism after bariatric surgery in morbid obesity patients;…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Cardiovascular Complications and COVID-19 (CovCardioVasc-Study)
CovCardioVasc-Study, a trial investigating cardiovascular complications in COVID-19, has completed.
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE) [NA]
The CLODETTE study at University Hospital, Bordeaux is an ongoing clinical trial investigating whether clonal hematopoiesis of indeterminate…
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Peri-procedural Management of Direct Oral Anticoagulants for Central VENOus Catheters in CAncer Patients With Venous Thromboembolism or Atrial Fibrillation Pilot Study [NA]
A pilot clinical trial evaluating peri-procedural management of direct oral anticoagulants in cancer patients undergoing central venous cath…
-
CLINICAL_TRIALS withdrawal · 2025-03-19Clinical Trial Update: THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS) [Phase 3]
A Phase 3 trial evaluating thromboprophylaxis in sickle cell disease patients with central venous catheters has been terminated.
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets [Phase 3]
Phase 3 clinical trial evaluating the best antithrombotic therapy for acute venous thromboembolism in patients already taking antiplatelets;…